» Articles » PMID: 26598570

Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions

Overview
Specialty Tropical Medicine
Date 2015 Nov 25
PMID 26598570
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The health-care needs and resources of disease-endemic regions such as west Africa have been a major focus during the recent Ebola outbreak. On the basis of that experience, we call attention to two priorities that have unfortunately been ignored thus far: 1) the development of clinical research facilities and 2) the training of host country investigators to ensure that the facilities and expertise necessary to evaluate candidate interventions are available on-site in endemic regions when and where they are needed. In their absence, as illustrated by the recent uncertainty about the use of antivirals and other interventions for Ebola virus disease, the only treatment available may be supportive care, case fatality rates may be unacceptably high and there may be long delays between the time potential interventions become available and it becomes clear whether those interventions are safe or effective. On the basis of our experience in Mali, we urge that the development of clinical research facilities and the training of host country investigators be prioritized in disease-endemic regions such as west Africa.

Citing Articles

Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Sigfrid L, Maskell K, Bannister P, Ismail S, Collinson S, Regmi S BMC Med. 2020; 18(1):190.

PMID: 32586391 PMC: 7315698. DOI: 10.1186/s12916-020-01624-8.


Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries.

Kayem N, Rojek A, Denis E, Salam A, Reis A, Olliaro P Emerg Infect Dis. 2019; 25(11):2084-2087.

PMID: 31625845 PMC: 6810185. DOI: 10.3201/eid2511.180628.


Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali.

Shaffer J, Mather F, Wele M, Li J, Tangara C, Kassogue Y Front Genet. 2019; 10:331.

PMID: 31031807 PMC: 6473184. DOI: 10.3389/fgene.2019.00331.


Development of a data collection and management system in West Africa: challenges and sustainability.

Shaffer J, Doumbia S, Ndiaye D, Diarra A, Gomis J, Nwakanma D Infect Dis Poverty. 2018; 7(1):125.

PMID: 30541626 PMC: 6292095. DOI: 10.1186/s40249-018-0494-4.


AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.

Koita O, Sangare L, Miller H, Sissako A, Coulibaly M, Thompson T Lancet Infect Dis. 2017; 17(12):1266-1275.

PMID: 28916443 PMC: 5700806. DOI: 10.1016/S1473-3099(17)30365-1.


References
1.
Towner J, Rollin P, Bausch D, Sanchez A, Crary S, Vincent M . Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004; 78(8):4330-41. PMC: 374287. DOI: 10.1128/jvi.78.8.4330-4341.2004. View

2.
Leroy E, Baize S, Lu C, McCormick J, Georges A, Georges-Courbot M . Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol. 2000; 60(4):463-7. View

3.
De D, Krogstad F, Cogswell F, Krogstad D . Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1996; 55(6):579-83. DOI: 10.4269/ajtmh.1996.55.579. View

4.
Henao-Restrepo A, Longini I, Egger M, Dean N, Edmunds W, Camacho A . Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015; 386(9996):857-66. DOI: 10.1016/S0140-6736(15)61117-5. View

5.
Brady O . Scale up the supply of experimental Ebola drugs. Nature. 2014; 512(7514):233. DOI: 10.1038/512233a. View